Spain’s ongoing LAMA2-CMD natural history study
In 2022, a natural history study was initiated with LAMA2-CMD patients at Barcelona’s Vall d’Hebron Institute of Research. Natural history…
In 2022, a natural history study was initiated with LAMA2-CMD patients at Barcelona’s Vall d’Hebron Institute of Research. Natural history…
Whilst there are currently no available treatments for LAMA2-CMD, several potential therapeutic approaches are under development and investigation. This article…
SEAL Therapeutics was established in late 2021 by Prof. Markus Rüegg, Dr. Judith Reinhard, both from the Biozentrum, and Dr.…
Heavyweight kickboxing world champion Rico Verhoeven met up with some of the LAMA2-CMD family in The Netherlands last December 2023. …
Meet 25-year-old Mo and 16-year-old Hidde from The Netherlands, both living with LAMA2-CMD. In this short documentary produced by the…
In september 2023 we started the LAMA2-CMD consortium meetings for researchers, clinicians, companies and patients and their representatives. These meetings…